Difference between revisions of "DSCAM-AS1"
Line 3: | Line 3: | ||
DSCAM-AS1 (DSCAM antisense RNA 1) | DSCAM-AS1 (DSCAM antisense RNA 1) | ||
[[File:Characterization of DSCAM-AS1.jpg|right|thumb|400px|'''Characterization of DSCAM-AS1'''<ref name="ref1" />]] | [[File:Characterization of DSCAM-AS1.jpg|right|thumb|400px|'''Characterization of DSCAM-AS1'''<ref name="ref1" />]] | ||
+ | [[File:Physical and functional relationship of DSCAM-AS1 with hnRNPL.jpg|right|thumb|400px|'''Physical and functional relationship of DSCAM-AS1 with hnRNPL'''<ref name="ref1" />]] | ||
+ | |||
===Synonyms=== | ===Synonyms=== | ||
M41 | M41 |
Revision as of 02:52, 13 November 2017
Contents
Annotated Information
Approved Symbol
DSCAM-AS1 (DSCAM antisense RNA 1)
Synonyms
M41
Chromosome
21q22.2
RefSeq ID
NR_038896
RefSeq(supplied by NCBI)
NR_038896
pubmed IDs
27666543
Disease
breast cancer
Characteristics
ER preferentially binds to the DSCAM-AS1 promoter in tumours with clinical aggression.[1]
Function
DSCAM-AS1 mediates tumour progression and tamoxifen resistance.[1] DSCAM-AS1 provides oestrogen-independent growth and a proliferative advantage when grown in oestrogen-deprived medium compared to normal serum.[1]
Regulation
hnRNPL is an interacting protein involved in the mechanism of DSCAM-AS1 action.[1]
Expression
DSCAM-AS1 expression is highly enriched in ER-positive tumours.[1]
Labs working on this lncRNA
- Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
- Department of Cellular and Molecular Biology, University of Michigan, Ann Arbor, Michigan 48109, USA.